Exhibit 16.1
February 2, 2024
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read MedAvail Holdings, Inc.’s statements included under Item 4.01(a) of its Form 8-K filed on February 2, 2024 and we agree with such statements concerning our firm.
/s/ SingerLewak LLP
| 10960 Wilshire Blvd, Suite 1100 Los Angeles California 90024 | T: 310.477.3924 | F: 310.478.6070 |